Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

BIOSU

BioPlus Acquisition (BIOSU)

BioPlus Acquisition Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BIOSU
DateTimeSourceHeadlineSymbolCompany
10/16/20233:15PMEdgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:BIOSUBioPlus Acquisition Corporation
10/04/20236:39AMEdgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:BIOSUBioPlus Acquisition Corporation
10/04/20236:32AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOSUBioPlus Acquisition Corporation
10/04/20236:30AMGlobeNewswire Inc.BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to LiquidateNASDAQ:BIOSUBioPlus Acquisition Corporation
09/15/20233:00PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:BIOSUBioPlus Acquisition Corporation
08/16/20238:01AMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:BIOSUBioPlus Acquisition Corporation
08/14/20233:11PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BIOSUBioPlus Acquisition Corporation
07/17/20237:01AMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:BIOSUBioPlus Acquisition Corporation
06/14/20235:09AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSUBioPlus Acquisition Corporation
06/14/20235:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOSUBioPlus Acquisition Corporation
05/30/20233:04PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSUBioPlus Acquisition Corporation
05/19/20233:50PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSUBioPlus Acquisition Corporation
05/19/20233:05PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSUBioPlus Acquisition Corporation
05/15/20233:29PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSUBioPlus Acquisition Corporation
05/15/20235:38AMEdgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:BIOSUBioPlus Acquisition Corporation
05/12/20233:17PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BIOSUBioPlus Acquisition Corporation
05/03/20237:47AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSUBioPlus Acquisition Corporation
05/03/20237:44AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOSUBioPlus Acquisition Corporation
04/27/20233:35PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:BIOSUBioPlus Acquisition Corporation
02/14/20232:39PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BIOSUBioPlus Acquisition Corporation
02/02/20239:10AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BIOSUBioPlus Acquisition Corporation
11/03/20224:10PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSUBioPlus Acquisition Corporation
10/11/20223:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOSUBioPlus Acquisition Corporation
08/10/20223:33PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSUBioPlus Acquisition Corporation
05/12/20223:55PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSUBioPlus Acquisition Corporation
03/11/20223:05PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:BIOSUBioPlus Acquisition Corporation
02/09/20221:14PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BIOSUBioPlus Acquisition Corporation
12/06/20217:00AMGlobeNewswire Inc.BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public OfferingNASDAQ:BIOSUBioPlus Acquisition Corporation
12/02/20217:55PMGlobeNewswire Inc.BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public OfferingNASDAQ:BIOSUBioPlus Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:BIOSU